UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outbursts of Cygnus X-3 observed at 1.3 and 3.3 mm wavelengths

Nature (London), 1986-11, Vol.324 (6092), p.39-40

1986

Volltextzugriff (PDF)

Reduction of Tropospheric Noise Fluctuations at Centimetre Wavelengths

Nature (London), 1966-01, Vol.212 (5061), p.494-495

BAARS, J. W. M

1966

Volltextzugriff (PDF)

A Radio Investigation of NGC 1265 and NGC 1275

Nature (London), 1965-01, Vol.205 (4970), p.488-489

1965

Volltextzugriff (PDF)

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Leukemia, 2016-02, Vol.30 (2), p.337-345

2016

Volltextzugriff (PDF)

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Leukemia, 2016-09, Vol.30 (9), p.1963-1963

2016

Volltextzugriff (PDF)

Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils

Leukemia, 2002-04, Vol.16 (4), p.693-699

2002

Volltextzugriff (PDF)

Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy

Leukemia, 2003-08, Vol.17 (8), p.1658-1664

2003

Volltextzugriff (PDF)

Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Leukemia, 2016-09, Vol.30 (9), p.1963-1963

2016

Volltextzugriff (PDF)

The pan phosphoinositide 3-kinase mammalian target of rapamycin inhibitor SAR245409

Leukemia, 2016-09, Vol.30 (9), p.1963

2016

Volltextzugriff (PDF)

Flow cytometric analysis of normal B cell differentiation : a frame of reference for the detection of minimal residual disease in precursor-B-ALL

Leukemia, 1999-03, Vol.13 (3), p.419-427

1999

Volltextzugriff (PDF)

BIOMED-1 Concerted Action report : Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

Leukemia, 2000-05, Vol.14 (5), p.816-825

2000

Volltextzugriff (PDF)

Biomed-i concerted action report: Flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

Leukemia, 2001, Vol.15 (8), p.1185-1192

2001

Volltextzugriff (PDF)

Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer

Bone marrow transplantation (Basingstoke), 2001-07, Vol.28 (2), p.173-180

2001

Volltextzugriff (PDF)

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

Leukemia, 2001-08, Vol.15 (8), p.1185-1192

2001

Volltextzugriff (PDF)

BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation

Leukemia, 2001-08, Vol.15 (8), p.1185-1192

2001

Volltextzugriff (PDF)

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7 super(+) cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

Leukemia, 2000-05, Vol.14 (5), p.816-825

2000

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Nature
(16)
Journals@Ovid Ovid Full Text
(14)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(13)
MEDLINE
(7)
Connected Ingenta
(4)
EBSCOhost Psychology and Behavioral Sciences Collection
(3)
Single Journals
(3)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Outbursts of Cygnus X-3 observed at 1.3 and 3.3 mm wavelengths

Reduction of Tropospheric Noise Fluctuations at Centimetre Wavelengths

A Radio Investigation of NGC 1265 and NGC 1275

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils

Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy

Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

The pan phosphoinositide 3-kinase mammalian target of rapamycin inhibitor SAR245409

Flow cytometric analysis of normal B cell differentiation : a frame of reference for the detection of minimal residual disease in precursor-B-ALL

BIOMED-1 Concerted Action report : Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

Biomed-i concerted action report: Flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7 super(+) cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

Aktive Filter

Suchergebnisse filtern